Actelion Pharmaceuticals Ltd
Actelion Pharmaceuticals Ltd., a leading biopharmaceutical company headquartered in Switzerland (CH), has established itself as a pioneer in the treatment of pulmonary arterial hypertension (PAH) and other serious conditions. Founded in 1997, Actelion has achieved significant milestones, including its acquisition by Johnson & Johnson in 2017, which further solidified its market position.
The company focuses on innovative therapies, particularly in the areas of cardiovascular and infectious diseases, with a portfolio that includes unique products like Tracleer and Opsumit. These therapies are distinguished by their targeted mechanisms and proven efficacy, addressing unmet medical needs. Actelion's commitment to research and development has positioned it as a key player in the biopharmaceutical industry, recognised for its contributions to improving patient outcomes globally.
+45 vs industry average
Actelion Pharmaceuticals Ltd’s score of 74 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Actelion Pharmaceuticals Ltd?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Reported emissions
No reported emissions data is available for Actelion Pharmaceuticals Ltd yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Actelion Pharmaceuticals Ltd’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Actelion Pharmaceuticals Ltd yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Johnson & Johnson
Carbon Disclosure Project
Inherited from Johnson & JohnsonThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Inherited from Johnson & JohnsonClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project